An investigation for shareholders in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares over potential securities laws violations by Vertex Pharmaceuticals was announced and NASDAQ:VRTX stockholders should contact the Shareholders Foundation.
San Diego, CA -- (SBWIRE) -- 12/09/2015 -- An investigation for shareholders in NASDAQ:VRTX shares over potential securities laws violations by Vertex Pharmaceuticals was announced.
Investors who purchased shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by Vertex Pharmaceuticals regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
On October 30, 2015, Vertex Pharmaceuticals Incorporated disclosed receipt of a subpoena from the U.S. Department of Justice, seeking information "relating primarily to [the company's] Good Laboratory Practices in a bioanalytical laboratory." Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) closed on November 6, 2015, at $117.96 per share.
Those who purchased shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com